2001
DOI: 10.1016/s1471-0153(00)00021-0
|View full text |Cite
|
Sign up to set email alerts
|

Psychoactive substance consumption in eating disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
16
1
4

Year Published

2005
2005
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 22 publications
1
16
1
4
Order By: Relevance
“…Food ingestion or deprivation, as well as psychoactive substance consumption, would constitute responses to experiencing such intense reactions. The frequency of substance use disorders (alcohol, drugs, psychotropic medications) associated with the increase in eating disorders supports the view that addiction is an important parameter to consider in the process of understanding emotional functioning abilities in eating disorders (Corcos et al, 2001). So does the demonstration of increased secretion of cerebral b-endorphin in patients with anorexia nervosa and bulimia nervosa (Bergh & Soderstein, 1996;Fullerton, 1986;Hawkes, 1992).…”
Section: Discussionmentioning
confidence: 66%
“…Food ingestion or deprivation, as well as psychoactive substance consumption, would constitute responses to experiencing such intense reactions. The frequency of substance use disorders (alcohol, drugs, psychotropic medications) associated with the increase in eating disorders supports the view that addiction is an important parameter to consider in the process of understanding emotional functioning abilities in eating disorders (Corcos et al, 2001). So does the demonstration of increased secretion of cerebral b-endorphin in patients with anorexia nervosa and bulimia nervosa (Bergh & Soderstein, 1996;Fullerton, 1986;Hawkes, 1992).…”
Section: Discussionmentioning
confidence: 66%
“…(40). Finally, there is some evidence that eating disorders, particularly bulimia nervosa (BN), are associated with the use of psychoactive substances (41). Most of these human studies point to the pathological basis of food addiction as a real disorder, although the role of dopaminergic neurotransmission in this context is not clear.…”
Section: Food Addictionmentioning
confidence: 99%
“…50% of AN patients will develop bulimic symptoms and migrate to a binge/purge subtype of AN and one third of those with BN have a history of AN (Bulik et al, 1997b;Eckert et al, 1995;Eddy et al, 2007;Eddy et al, 2002;Strober et al, 1997;Tozzi et al, 2005 SMR BN: 2.0 (95% CI) Prevalence Prevalence AN: 0.2 and 0.5% BN: 1.1-4.2% Course and outcome Course and outcome AN: less favourable than BN (Fichter & Quadflieg, 2004) BN: more favourable than AN (Fichter & Quadflieg, 2004) Addiction Liability Addiction Liability AN: AN-R shows significantly less drug-consumption behaviours and alcohol abuse (Corcos et al, 2001) BN: BN shows a significantly higher risk of developing a psychoactive substance dependence during his/her lifetime. (Bulik, 1987;Bulik et al, 1997a;Dansky et al, 2000;Goodman, 2007;Herzog et al, 2006;Holderness et al, 1994;Jones et al, 1985;Lacey, 1993;Mitchell et al, 1985;Mitchell et al, 1991;Welch & Fairburn, 1996;Wilson, 1992) Genetics Genetics Linkage analysis: less number of linkage signals, with minimal overlap with BN (Bacanu et al, 2005) Linkage analysis: greater number of linkage signals, with minimal overlap with AN (Bacanu et al, 2005) Susceptibility locus: chromosome 1 (Grice et al, 2002), 2, and 13 (Devlin et al, 2002) with inclusion of core behavioural covariates Susceptibility locus: chromosome 10p,with a suggestive linkage on chromosome 14 (Bulik et al, 2003 …”
Section: Consistencymentioning
confidence: 99%
“…A person who has been diagnosed with BN is at a significantly higher risk than is the general population to develop, during his or her lifetime, a psychoactive substance dependence (Bulik, 1987;Bulik, Sullivan, Carter, & Joyce, 1997a;Dansky, Brewerton, & Kilpatrick, 2000;Goodman, 2007;Herzog, Franko, Dorer, Keel, Jackson, & Manzo, 2006;Holderness, Brooks-Gunn, & Warren, 1994;Jones, Cheshire, & Moorhouse, 1985;Lacey, 1993;Mitchell et al, 1985;Mitchell, Specker, & de Zwaan, 1991;Welch & Fairburn, 1996;Wilson, 1992). On the other hand, a person who has been diagnosed with AN restrictive (AN-R) shows significantly less drug-consumption behaviours and alcohol abuse and/or dependence disorders than AN binge purge (AN-B) and BN patients (Corcos et al, 2001). This difference in co-morbidity with substance use disorders suggests a different vulnerability to addiction and dependence and possibly the intensity of the addictive behaviours and of the associated co-morbidity (Corcos et al, 2001).…”
Section: Coherencementioning
confidence: 99%